Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
J Alzheimers Dis. 2018;63(1):69-73. doi: 10.3233/JAD-180050.
Referring to recent international articles stating that amyloid imaging or detection has a high additive value in making a diagnosis of Alzheimer's disease (AD) when previous investigations are inconclusive, the authors of this editorial argue that this statement is based on circular reasoning and, hence, misleading. Since autopsy findings and other potential indicators fit poorly with amyloid PET, they conclude that this examination has no role in the diagnosis of AD.
针对近期国际文章提出的，在先前的研究结果不确定的情况下，淀粉样蛋白成像或检测对阿尔茨海默病（AD）的诊断具有较高的附加价值的观点，本文编辑认为，这种说法基于循环推理，因此具有误导性。由于尸检结果和其他潜在的指标与淀粉样蛋白 PET 不匹配，他们得出结论，这种检查在 AD 的诊断中没有作用。
